摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴苯硼酸N-甲基二乙醇胺酯 | 115247-41-1

中文名称
4-溴苯硼酸N-甲基二乙醇胺酯
中文别名
——
英文名称
4-bromo N-methyl-diethanolamine phenylboronate
英文别名
(4-bromophenyl)boronic acid N-methyl-O,O-diethanolamine ester;4-bromobenzeneboronic acid N-methyldiethanolamine cyclic ester;2-(4-bromophenyl)-6-methyl-1,3,6,2-dioxyazaborocane;2-(4-bromo-phenyl)-6-methyl-[1,3,6,2]dioxazaborocane;p-bromo-benzeneboronic acid, (methylimino)diethylene ester;4-bromobenzeneboronic acid N-methyldiethanolamine ester;2-(4-Brom-phenyl)-6-methyl-[1,3,6,2]dioxazaborocan;2-(4-Bromophenyl)-6-methyl-1,3,6,2-dioxazaborocane
4-溴苯硼酸N-甲基二乙醇胺酯化学式
CAS
115247-41-1
化学式
C11H15BBrNO2
mdl
——
分子量
283.961
InChiKey
OSYBCIKXYVRFGE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    364.719±37.00 °C(Press: 760.00 Torr)(predicted)
  • 密度:
    1.368±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.12
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    21.7
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温,惰性气氛

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] HALO SULFONYL ARYL BORONATES<br/>[FR] HALO SULFONYL ARYL BORONATES
    申请人:NOVO NORDISK AS
    公开号:WO2004041833A1
    公开(公告)日:2004-05-21
    The present invention relates to halo sulfonyl aryl boronates of the general formula (I): wherein Arylene designates a carbocyclic or heterocyclic, aromatic ring system comprising 1-3 rings; R1, R2 and R3 are, independently, hydrogen, C1-6alkyl, C1-6alkoxy, halogen, nitro, cyano or phenyl;X is fluoro, chloro or bromo; and Y is a boroxine moiety attached via a bond from Arylene to one of the boron atoms of a boroxine ring which ring has a group of the formula -Arylene(R1)(R2)(R3)SO2X, wherein Arylene, R1, R2, R3 and X are as defined above, at each of the other two boron atoms of the boroxine ring, or Y is a boronic acid group or a boronic ester group.The invention also relates to the preparation of the compounds of formula (I) and to their use in organic synthesis.
    本发明涉及一般式(I)的卤磺酰基芳基硼酸酯,其中芳烃代表一个包含1-3个环的碳环或杂环芳香环系统;R1、R2和R3分别是氢、C1-6烷基、C1-6烷氧基、卤素、硝基、基或苯基;X是;Y是通过一种键连接到芳烃上的氧杂环部分,该氧杂环具有一个式为-Arylene(R1)(R2)(R3)SO2X的基团,其中Arylene、R1、R2、R3和X如上定义,在氧杂环的另外两个原子上,或Y是硼酸基团或酯基团。该发明还涉及一般式(I)化合物的制备以及它们在有机合成中的应用。
  • Synthesis and Activity of a Novel Series of 3-Biarylquinuclidine Squalene Synthase Inhibitors
    作者:George R. Brown、David S. Clarke、Alan J. Foubister、Susan Freeman、Peter J. Harrison、Michael C. Johnson、Keith B. Mallion、John McCormick、Fergus McTaggart、Alan C. Reid、Graham J. Smith、Melvyn J. Taylor
    DOI:10.1021/jm950907l
    日期:1996.1.1
    Quinuclidines with a 3-biaryl substituent are a new class of potent, orally active squalene synthase (SQS) inhibitors. Variants around these rigid structures indicate key structural requirements for cationic SQS inhibitors. Thus the lower in vitro potency found for quinuclidines bearing 3-substituents, which did not overlay the biphenyl group of 3-(biphenyl-4-yl)-3-hydroxyquinuclidine (2) (IC50 = 16
    具有3-联芳基取代基的喹核苷是一类新的有效的,口服活性的角鲨烯合酶(SQS)抑制剂。这些刚性结构周围的变化指示出阳离子SQS抑制剂的关键结构要求。因此,暗示了带有3个取代基的喹核苷的体外效价较低,该奎尼啶没有覆盖3-(联苯基-4-基)-3-羟基喹核苷(2)的联苯基团(IC50 = 16 nM,大鼠微粒体SQS)。 3取代基的方向性要求。类似地,3-三联苯类似物6的较低效能(IC50 = 370 nM)表明该取代基的尺寸受到限制。在具有奎宁环联苯环之间连接基团的化合物中,亲脂性较低的连接基团的耐受性较差(例如,17,CH2CH2,IC50 = 5 nM与19,NHCO,IC50 = 1.2 microM)。用更具极性的吡啶杂环取代2的远端苯环会导致体外效能降低。通常,大鼠体内的良好体内活性仅限于3-羟基类似物,其中3- [4-(吡啶-4-基)苯基]衍生物39(IC50 = 161 nM)显示出最佳的抑制作用(口服给药后)
  • Synthesis and evaluation of thiazolidinedione and dioxazaborocane analogues as inhibitors of AI-2 quorum sensing in Vibrio harveyi
    作者:Gilles Brackman、Abed Al Aziz Al Quntar、Claes D. Enk、Izet Karalic、Hans J. Nelis、Serge Van Calenbergh、Morris Srebnik、Tom Coenye
    DOI:10.1016/j.bmc.2012.11.055
    日期:2013.2
    Two focused libraries based on two types of compounds, that is, thiazolidinediones and dioxazaborocanes were designed. Structural resemblances can be found between thiazolidinediones and well-known furanone type quorum sensing (QS) inhibitors such as N-acylaminofuranones, and/or acyl-homoserine lactone signaling molecules, while dioxazaborocanes structurally resemble previously reported oxazaborolidine derivatives which antagonized autoinducer 2 (AI-2) binding to its receptor. Because of this, we hypothesized that these compounds could affect AI-2 QS in Vibrio harveyi. Although all compounds blocked QS, the thiazolidinediones were the most active AI-2 QS inhibitors, with EC50 values in the low micromolar range. Their mechanism of inhibition was elucidated by measuring the effect on bioluminescence in a series of V. harveyi QS mutants and by DNA-binding assays with purified LuxR protein. The active compounds neither affected bioluminescence as such nor the production of AI-2. Instead, our results indicate that the thiazolidinediones blocked AI-2 QS in V. harveyi by decreasing the DNA-binding ability of LuxR. In addition, several dioxazaborocanes were found to block AI-2 QS by targeting LuxPQ. (C) 2012 Elsevier Ltd. All rights reserved.
  • N-ARYL-SUBSTITUTED CYCLIC AMINE DERIVATIVE AND MEDICINE CONTAINING THE SAME AS ACTIVE INGREDIENT
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1375496B1
    公开(公告)日:2007-07-04
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫